Clinical trials in Tauberbischofsheim

Clinical trials focusing on meningococcal infection prevention are being conducted, evaluating the long-term effectiveness of vaccination strategies in young populations.

• Vaccine Immunogenicity Studies
• Long-term Protection Assessment
• Pediatric Vaccine Safety

Research examines immune responses in children and adolescents who received initial vaccination as toddlers, with particular attention to quadrivalent meningococcal protection over extended periods.

Ongoing studies evaluate booster dose effectiveness in different age groups, from children to adolescents, examining both 5-year and 10-year intervals post-initial vaccination.

• Age-Specific Response Analysis
• Immune Persistence Monitoring
• Multi-Country Clinical Assessment

The research spans multiple European countries, including Finland, Germany, Spain, and Hungary, focusing on preventive medicine approaches.

Comprehensive evaluation of vaccine safety profiles in conjunction with immunogenicity assessments across different age groups and time intervals.

• Safety Parameter Analysis
• Seroresponse Assessment
• Long-term Follow-up Studies

Research focuses on multiple meningococcal serogroups (A, C, W, and Y), examining protective immune responses after booster administration.